Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Wyoming for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Wyoming only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Wyoming (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Laurie Johnson (NPI 1316954688)

Field	Value
Entity Type	Individual
Organization	Laurie Johnson
Address	6501 E 2nd St
City	Casper
State	WY
ZIP	82609
Taxonomy	Physician Assistant
NPI Enumerated	August 1, 2006

Payer Source	Total Paid
Medicare	$612.5K
Medicaid	$0

Key Findings

Medicare revenue is concentrated almost entirely in a few infusion and clinic visit codes: the precomputed top 3 Medicare codes by revenue account for 92.7% of this provider's total Medicare revenue, driving the bulk of the reported $612.5K in Medicare receipts. This extreme concentration means most of the practice’s Medicare dollars come from a narrow set of services rather than a broad mix of outpatient care.

The single largest revenue driver is J9271 (pembrolizumab), which generates $447.2K and represents 73.6% of this provider’s Medicare revenue; this suggests the practice operates primarily as an oncology/infusion site administering high-cost monoclonal antibody therapy. Secondary revenue comes from J0897 (denosumab) at $77.8K (12.8%) and 99214 office visits at $38.5K (6.3%), indicating a service model combining high-volume biologic infusions with evaluation-and-management follow-up.

This provider appears effectively single-payer in the observed dataset: Total Medicare revenue is $612.5K while there is no Medicaid billing on file, so the practice’s public-payer exposure is concentrated in Medicare rather than a mixed Medicare–Medicaid payer mix. Analysts should treat the profile as Medicare-dominant and not expect Medicaid volume to meaningfully diversify revenue or utilization patterns.

Competitive standing by code is modest to mixed: J9271 ranks #1128 of 1841 providers nationally (38th percentile) and is described in the source as "typical, unremarkable volume for this code," indicating this provider is not a national leader for pembrolizumab despite the large share of its own revenue coming from it. J0897 ranks #3274 of 10057 providers (67th percentile) and 99214 ranks #55194 of 479517 providers (88th percentile), each also labeled "typical, unremarkable volume for this code," so the provider’s absolute activity on some codes is above median but still within typical industry variation rather than an outlier.

The broader code mix supports an integrated infusion practice with on-site monitoring and supportive care rather than a pure office-only model: additional chemotherapy/infusion administration codes such as 96413 ($8.5K), 96367 ($3.4K), and 96365 ($2.6K) appear on the file, and supportive antiemetic J2469 shows 460 claims for $460 in revenue. Routine lab monitoring also appears regularly (e.g., 36415 with 393 claims/$3.1K, 80053 with 291 claims/$2.9K, and 85025 with 249 claims/$2.0K), consistent with ongoing infusion management and follow-up.

The provider has long-standing enrollment in federal programs, with NPI enumeration dated 2006-08-01 (~20 years ago), which suggests operational stability and sustained participation in Medicare billing over an extended period. This tenure, combined with a concentrated revenue mix, implies an established clinical focus (oncology infusion) that has been maintained over many years.

High revenue dependence on a single product is notable from a business risk perspective: J9271 alone accounts for $447.2K and 73.6% of Medicare revenue, so changes in pembrolizumab prescribing, payer coverage, or reimbursement could materially affect the practice’s Medicare income. Given that the top three codes together make up 92.7% of Medicare revenue, the practice’s financial performance on public payers is highly sensitive to volume and reimbursement trends for a very small set of services.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

27 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	10,400	$40	$447.2K
J0897	Injection, denosumab, 1 mg	4,320	$20	$77.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	460	$80	$38.5K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	190	$50	$10.5K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	100	$90	$8.5K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	40	$110	$3.9K
96367	The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose…	170	$20	$3.4K
36415	In this procedure, the provider inserts a needle into a vein to collect a blood sample.	390	$10	$3.1K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	290	$10	$2.9K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	60	$40	$2.6K

Showing 1–10 of 27

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 27 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Wyoming Distribution

Laurie Johnson — 0 of 24 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Wyoming

Full comparison — all codes billed, vs. state median

27 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	3	10	12,500	$40	$528K
J0897	8	50	1,800	$20	$51.1K
96413	5	10	150	$100	$22.9K
99214	80	780	100	$80	$14.8K
96365	8	10	220	$50	$13.4K
99213	249	850	110	$60	$9.9K
96367	4	10	180	$20	$7.8K
99204	155	340	30	$110	$5K
96417	5	10	70	$50	$4.9K
96415	4	10	100	$20	$2.6K

Showing 1–10 of 27

Related Providers

Other providers that share a Tax Identification Number (TIN) with Laurie Johnson, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Douglas Holmes	WY	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Brittney Statler	CO	Ophthalmology Physician	$3.7M	$0
Arthur Korotkin	CO	Ophthalmology Physician	$3.7M	$0
John Purviance	WY	Radiation Oncology Physician	$2.5M	$0
Cary Chisholm	TX	Anatomic Pathology & Clinical Pathology Physician	$2.5M	$24.7K
Matthew Asano	CO	Ophthalmology Physician	$2M	$0
Stacey Wells	AK	Radiation Oncology Physician	$2M	$0
Elie Fahed	WY	Medical Oncology Physician	$1.9M	$0
Peter Hovland	CO	Ophthalmology Physician	$1.8M	$0
James Levine	CO	Rheumatology Physician	$1.7M	$0

Nearby Providers

Other providers in the same ZIP code as Laurie Johnson, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Northwest Community Action Programs Of Wyoming, Inc.	WY	Developmentally Disabled Services Day Training Agency	$0	$25.8M
Community Health Center Of Central Wyoming, Inc.	WY	Federally Qualified Health Center (FQHC)	$0	$15.3M
Emg Casper Mw LLC	WY	Assisted Living Facility	$0	$5.9M
Casper Children's Center, LLC	WY	Pediatrics Physician	$0	$4M
Wyoming Behavioral Institute	WY	Psychiatric Hospital	$0	$2.7M
Stephen Brown	WY	Child & Adolescent Psychiatry Physician	$0	$2.4M
2nd Street Dental, LLC	WY	Dental Clinic/Center	$0	$2.4M
Solutions Counseling Services LLC	WY	Community/Behavioral Health Agency	$0	$2.1M
Surfin Smiles LLC	WY	Pediatric Dentistry	$0	$2M
Robert Peterson	WY	School Psychologist	$0	$1.9M

Laurie Johnson — Billing Profile & Reimbursement Data

Sign up for Laurie Johnson — Billing Profile & Reimbursement Data policy alerts

Laurie Johnson — Billing Profile & Reimbursement Data

Sign up for Laurie Johnson — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References